Physician Andrew Wakefield reported in 1998 that the measles vaccine leads to autism. Even though his research was discredited, the damage was done and there came a fall in measles vaccinations due to which the prevalence of measles increased.
The jury at the St. Louis court announced its verdict against J&J last month, giving a major blow to the company as it now has to pay about $4.7 billion to 22 women or their loved-ones for the claim that it’s talc caused ovarian cancer.
Findings from a new study revealed that e-cigarette vapor is responsible for the development of inflammatory mediators in the lungs and also for the hampering of chief disease-fighting cells.
Cinnamon, the Queen of Spices, has been a much-loved addition to food for the better part of a thousand years. The reason behind its effect includes increased fragrance in foods in addition to its medicinal uses.
Artios Pharma, a U.K. based company in Cambridge, has raised $84 million to take DNA damage response (DDR) programs to the next level of clinical proof of concept.
Annovera (segesterone acetate and ethinyl estradiol vaginal system), a multi-use donut-shaped ring, was recently approved and presented to the Population Council by the FDA.
A study published online in The Lancet Oncology showed a score integrating clinical and biological markers which could help foresee the chance of mortality in patients with malignant pleural effusion and their probability of benefiting from pleurodesis.
Research shows that chief aspects of the aging of human cells can be inverted by new compounds developed at the University of Exeter.
HitGen and Merck have updated their licensing agreement to a full-fledged drug discovery collaboration in order to screen DNA-encoded libraries for new small-molecule assets.
Janssen Korea becomes yet another drugmaker to shut its Hyangnam plant in Hwaseong, South Korea, by 2021, stranding an uncounted number of employees.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.